EUCTR2006-003473-27-DE进行中（未招募）不适用
Wirkung von Telmisartan 80 mg im Vergleich zu Valsartan 160 mg auf die Insulinsensitivität (HOMA) - WITEVA - - WITEVA
MedQuality Forschung GmbH0 个研究点开始时间: 2006年10月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •essential hypertension (RRsyst.>140,RRdiast.>90 mmHG)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Creatinine Clearance < 30 ml /min
- •severe cardiac insufficiency (NYHY IV)
- •severe aortic stenosis
- •acute myocardial infarction within last 4 weeks
- •unstable angina
- •participation in another clinical trial within last 30 days
研究者
相似试验
已完成
不适用
Clinical effect of telmisartan versus valsartan on blood pressure during anesthesiaDiseases of the circulatory systemKCT0001595Konkuk University Medical Center300
已完成
3 期
The effect of Valsartan and Amlodipine combination with two different forms in controlling 24-hour ambulatory blood presureEssential Hypertension.Essential (primary) hypertensionIRCT20221016056199N1Shiraz University of Medical Sciences136
招募中
Unknown
Bioequivalence study of Telmisartan 80 mg tabletIRCT20200105046010N77Cobel Darou Pharmaceutical Company24
已完成
不适用
Effects of Telmisartan compared with Candesartan on ischemic cardiovascular events in high-risk hypertensive patients: a multi-center, prospective, randomized, open-labeled, blinded endpoints trialEssential hypertensionJPRN-UMIN000001762Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine1,500
招募中
Unknown
Investigating bioequivalence of valsartan tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N15Tabriz University of Medical Sciences24